179 related articles for article (PubMed ID: 37711064)
1. Low T3 syndrome predicts more adverse events in patients with hypertrophic cardiomyopathy.
He CJ; Zhu CY; Fan HY; Qian YZ; Zhai CL; Hu HL
Clin Cardiol; 2023 Dec; 46(12):1569-1577. PubMed ID: 37711064
[TBL] [Abstract][Full Text] [Related]
2. Association Between Depression and Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy.
Hu HL; Chen H; Zhu CY; Yue X; Wang HW; Qian G; Zhai CL; He CJ
J Am Heart Assoc; 2021 Apr; 10(8):e019071. PubMed ID: 33834850
[TBL] [Abstract][Full Text] [Related]
3. Anxiety Predicts Poor Prognosis in Patients With Hypertrophic Cardiomyopathy.
He CJ; Zhai CL; Huang SD; Fan HY; Qian YZ; Zhu CY; Hu HL
Front Cardiovasc Med; 2022; 9():890506. PubMed ID: 35665258
[TBL] [Abstract][Full Text] [Related]
4. Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients.
Drechsler C; Schneider A; Gutjahr-Lengsfeld L; Kroiss M; Carrero JJ; Krane V; Allolio B; Wanner C; Fassnacht M
Am J Kidney Dis; 2014 Jun; 63(6):988-96. PubMed ID: 24315768
[TBL] [Abstract][Full Text] [Related]
5. [Predicting value of 2014 European guidelines risk prediction model for sudden cardiac death (HCM Risk-SCD) in Chinese patients with hypertrophic cardiomyopathy].
Li WX; Liu LW; Wang J; Zuo L; Yang F; Kang N; Lei CH
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1033-1038. PubMed ID: 29325362
[No Abstract] [Full Text] [Related]
6. The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy.
Conway J; Min S; Villa C; Weintraub RG; Nakano S; Godown J; Tatangelo M; Armstrong K; Richmond M; Kaufman B; Lal AK; Balaji S; Power A; Baez Hernandez N; Gardin L; Kantor PF; Parent JJ; Aziz PF; Jefferies JL; Dragulescu A; Jeewa A; Benson L; Russell MW; Whitehill R; Rossano J; Howard T; Mital S
Circulation; 2023 Feb; 147(9):718-727. PubMed ID: 36335467
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of patients with hypertrophic cardiomyopathy and low-normal left ventricular ejection fraction.
Choi YJ; Kim HK; Hwang IC; Park CS; Rhee TM; Lee HJ; Park JB; Yoon YE; Lee SP; Cho GY; Kim YJ
Heart; 2023 Apr; 109(10):771-778. PubMed ID: 36581445
[TBL] [Abstract][Full Text] [Related]
8. [Long-term prognostic value of lowering in free triiodothyronine in patients with hypertrophic cardiomyopathy].
Meng XB; Wang WY; Zhang K; Qi Y; An SM; Wang SY; Zheng JL; Yu QJ; Tang B; Wu R; Gao CY; Wang SY; Tang YD
Zhonghua Nei Ke Za Zhi; 2018 Apr; 57(4):258-263. PubMed ID: 29614583
[No Abstract] [Full Text] [Related]
9. Thyroid hormone and coronary artery disease: from clinical correlations to prognostic implications.
Coceani M; Iervasi G; Pingitore A; Carpeggiani C; L'Abbate A
Clin Cardiol; 2009 Jul; 32(7):380-5. PubMed ID: 19609889
[TBL] [Abstract][Full Text] [Related]
10. [Impact of low T3 syndrome on adverse cardiovascular events in adult patients with acute viral myocarditis].
Zhao Y; Wang WY; Tian J; Zhang X; Yang M; Chen J; Mu M; Tang YD
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Jun; 47(6):447-451. PubMed ID: 31262128
[No Abstract] [Full Text] [Related]
11. Prognostic impact of mitral L-wave in patients with hypertrophic cardiomyopathy without risk factors for sudden cardiac death.
Sugiura Y; Morimoto R; Aoki S; Yamaguchi S; Haga T; Kuwayama T; Yokoi T; Hiraiwa H; Kondo T; Watanabe N; Kano N; Fukaya K; Sawamura A; Okumura T; Murohara T
Heart Vessels; 2019 Dec; 34(12):2002-2010. PubMed ID: 31152200
[TBL] [Abstract][Full Text] [Related]
12. The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy.
Klopotowski M; Kukula K; Malek LA; Spiewak M; Polanska-Skrzypczyk M; Jamiolkowski J; Dabrowski M; Baranowski R; Klisiewicz A; Kusmierczyk M; Jasinska A; Jarmus E; Kruk M; Ruzyllo W; Witkowski A; Chojnowska L
J Cardiol; 2016 Jul; 68(1):49-56. PubMed ID: 26363820
[TBL] [Abstract][Full Text] [Related]
13. Risk of Sudden Death in Patients With RASopathy Hypertrophic Cardiomyopathy.
Lynch A; Tatangelo M; Ahuja S; Steve Fan CP; Min S; Lafreniere-Roula M; Papaz T; Zhou V; Armstrong K; Aziz PF; Benson LN; Butts R; Dragulescu A; Gardin L; Godown J; Jeewa A; Kantor PF; Kaufman BD; Lal AK; Parent JJ; Richmond M; Russell MW; Balaji S; Stephenson EA; Villa C; Jefferies JL; Whitehill R; Conway J; Howard TS; Nakano SJ; Rossano J; Weintraub RG; Mital S
J Am Coll Cardiol; 2023 Mar; 81(11):1035-1045. PubMed ID: 36922089
[TBL] [Abstract][Full Text] [Related]
14. Validation of the hypertrophic cardiomyopathy risk-sudden cardiac death calculator in Asians.
Choi YJ; Kim HK; Lee SC; Park JB; Moon I; Park J; Kim YJ; Sohn DW; Ommen S
Heart; 2019 Dec; 105(24):1892-1897. PubMed ID: 31383719
[TBL] [Abstract][Full Text] [Related]
15. [The value of cardiac MRI in the risk stratification in patients with hypertrophic cardiomyopathy].
Wang JX; Yang SJ; Ma X; Yu SQ; Dong ZX; Xiang XR; Wei ZX; Cui C; Yang K; Chen XY; Lu MJ; Zhao SH
Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jun; 51(6):619-625. PubMed ID: 37312480
[No Abstract] [Full Text] [Related]
16. Association Between Low T3 Syndrome and Poor Prognosis in Adult Patients With Acute Myocarditis.
Zhao Y; Wang W; Zhang K; Tang YD
Front Endocrinol (Lausanne); 2021; 12():571765. PubMed ID: 33763025
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the new risk prediction model (HCM Risk-SCD) and classic risk factors for sudden death in patients with hypertrophic cardiomyopathy and defibrillator.
Ruiz-Salas A; García-Pinilla JM; Cabrera-Bueno F; Fernández-Pastor J; Peña-Hernández J; Medina-Palomo C; Barrera-Cordero A; De Teresa E; Alzueta J
Europace; 2016 May; 18(5):773-7. PubMed ID: 25855675
[TBL] [Abstract][Full Text] [Related]
18. The impact of hypertension on the prognosis of patients with hypertrophic cardiomyopathy: a single-center retrospective study.
Wang Z; Zheng Y; Ruan H; Li L; Zhang M; Duan L; He S
PeerJ; 2023; 11():e14614. PubMed ID: 36650838
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy.
Kubo T; Baba Y; Ochi Y; Hirota T; Yamasaki N; Kawai K; Yamamoto K; Kondo F; Bando K; Yamada E; Furuno T; Yabe T; Doi YL; Kitaoka H
ESC Heart Fail; 2021 Dec; 8(6):5022-5030. PubMed ID: 34472710
[TBL] [Abstract][Full Text] [Related]
20. N-terminal pro-brain natriuretic peptide and sudden cardiac death in hypertrophic cardiomyopathy.
Wu G; Liu J; Wang S; Yu S; Zhang C; Wang D; Zhang M; Yang Y; Kang L; Zhao S; Hui R; Zou Y; Wang J; Song L
Heart; 2021 Oct; 107(19):1576-1583. PubMed ID: 33361398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
